Purchase Order W81K0022P0227

Award Date 9/2/22
Potential Completion Date 9/30/22
Potential Value $57K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Medical Command
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
2330 Stanley Rd, Fort Sam Houston, TX 78234, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Health Agency (DHA) awarded a firm-fixed-price delivery order contract to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of a microbiology analyzer and consumables. The $87,980.77 contract has an ultimate completion date of December 16, 2022. Biomerieux Inc., through its Biomerieux, Inc. division, is the sole awardee and is not subject to any set-aside designations. The company is known for its proprietary diagnostic platforms, such as VITEK,...
This federal contract award, valued at $125,853.61, was issued by the Defense Health Agency (DHA) to Biomerieux Inc., a global leader in in vitro diagnostics. The contract, which does not have a set-aside designation, is for the provision of the VITEK automated microbial identification system and associated products and services. Biomerieux Inc., through its Biomerieux, Inc. division, is the sole source provider for this proprietary technology. The contract is a firm-fixed-price purchase order...
This firm-fixed-price purchase order was awarded by the Defense Health Agency (DHA) to Biomerieux Inc., a global leader in in vitro diagnostics. The contract, valued at $11,258.96, is for the provision of Biomerieux supplies and services, including its proprietary VITEK, BioFire, and VIDAS diagnostic platforms and associated reagents and test kits. Biomerieux, through its Biomerieux, Inc. division, has been a long-standing supplier of clinical diagnostic equipment and consumables to various...
This firm-fixed-price delivery order was awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense to Biomerieux Inc., a global leader in in vitro diagnostics, for the supply of VITEK 2 equipment. The $87,963.69 contract does not have a set-aside designation and utilizes Biomerieux's existing Multiple Award Schedule (MAS) contract with the General Services Administration. Biomerieux, through its Biomerieux, Inc. division, is the prime contractor and provides specialized...
This federal contract award to Biomerieux Inc., a global leader in in vitro diagnostics, is for the lease of VITEK 2 COMPACT 30 equipment. The $106,416.60 firm-fixed-price purchase order was awarded by the U.S. Army Medical Command (MEDCOM) and has an ultimate completion date of December 31, 2020. The contract does not have a set-aside designation. Biomerieux Inc., through its Biomerieux, Inc. division, provides a wide range of clinical diagnostic equipment, reagents, and supplies to various...
The federal contract award summarizes a $5,812 firm fixed-price delivery order issued by the Defense Health Agency to Biomerieux Inc., a global leader in in vitro diagnostics. The contract is for the provision of a "MICROBIOLOGY ANALYZER" and does not have a set-aside designation. Biomerieux Inc., through its Vitek Systems, Inc. division, is a key supplier of specialized diagnostic technologies to various government healthcare operations, including the Departments of Veterans...
The U.S. Defense Health Agency (DHA) awarded a $365,448.60 firm-fixed-price contract to Biomerieux Inc., doing business as Vitek Systems, Inc., for a VITEK 2 microbiology analyzer lease agreement. This is a definitive contract with a period of performance ending on July 14, 2028. The contract was not set aside for any particular business type. Biomerieux Inc. is a global leader in in vitro diagnostics, specializing in the manufacture and distribution of advanced microbiological testing...
This is a firm-fixed-price purchase order awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense to Biomerieux Inc., a global leader in in vitro diagnostics, for the supply of VITEK MS-CLINICAL SYSTEM. The contract has a ceiling value of $265,511.00 and a completion date of October 29, 2016. The contract does not have a set-aside designation, as Biomerieux is often the sole source provider for its proprietary technologies. Biomerieux has received numerous federal contracts...
This firm-fixed-price delivery order was awarded to Biomerieux Inc., a global leader in in vitro diagnostics, to provide an automated system for bacterial identification and susceptibility testing. The $514,338.42 contract was awarded by the Veterans Integrated Service Network 7 (VISN 7) of the U.S. Department of Veterans Affairs and does not have a set-aside designation. Biomerieux will supply its proprietary VITEK, BioFire, and VIDAS diagnostic systems and associated consumables to support...
This contract was awarded by the Defense Health Agency, a defense agency, to Biomerieux Inc., a for-profit manufacturer of medical diagnostic equipment and reagents. The $17,658.76 firm fixed-price purchase order is for a full-service plan, with an ultimate completion date of April 1, 2023. The contract does not have a set-aside designation. Biomerieux Inc., through its Vitek Systems, Inc. division, has been awarded numerous federal contracts and Indefinite Delivery Vehicles (IDVs) by agencies...

This firm-fixed-price purchase order was awarded by the Defense Health Agency (DHA) to Biomerieux Inc., a global leader in in vitro diagnostics, for the provision of a VITEK 2 COMPACT 30 automated microbial identification system. The $56,625.00 contract has a completion date of September 30, 2022 and does not involve any set-aside designation. Biomerieux, through its Biomerieux, Inc. Division, is the prime contractor and manufacturer of the supplied equipment. This award is likely part of Biomerieux's broader federal contract vehicles, such as its $194 million Federal Supply Schedule contract for In Vitro Diagnostics, Reagents, and Test Kits, which enables various government agencies to efficiently procure the company's specialized diagnostic platforms and consumables. The contract supports the DHA's healthcare operations and aligns with Biomerieux's expertise in providing advanced microbial identification and antibiotic susceptibility testing solutions to federal agencies, including the Departments of Veterans Affairs, Defense, and Health and Human Services.

Generated 10/9/24, 9:26 AM